PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Malcolm Moos of FDA/CBER/OCTGT to Present at the Stem Cell Summit 2013 on April 29-30 in Boston - Malcolm Moos, Medical Officer of Cellular,Tissue and Gene Therapies at the Center for Biologics Evaluation and Research of FDA will present at the Stem Cell Summit 2013 on April 29-30, 2013 in Boston, MA - GTCbio.com
Malcolm Moos of FDA/CBER/OCTGT to Present at the Stem Cell Summit 2013 on April 29-30 in Boston

 

NewswireToday - /newswire/ - Monrovia, CA, United States, 2013/04/11 - Malcolm Moos, Medical Officer of Cellular,Tissue and Gene Therapies at the Center for Biologics Evaluation and Research of FDA will present at the Stem Cell Summit 2013 on April 29-30, 2013 in Boston, MA - GTCbio.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Malcolm Moos, Medical Officer of Cellular, Tissue and Gene Therapies at the Center for Biologics Evaluation and Research of FDA will present on “Characterization of cell-based regenerative medicine products current challenges and possible solutions” at the Stem Cell Summit 2013 on April 29-30, 2013 in Boston, MA.

Therapeutic interventions with cells or engineered tissues promise to provide effective treatments for conditions refractory to conventional approaches. However, development of such products poses new obstacles. Because living cells and tissues cannot be sterilized, microbiological safety is an even greater concern than for other regulated products. The difficulty is compounded by product shelf lives that are often so short that conventional safety testing using compendial methods is not practical. Though rapid methods are under development, there is limited experience with these techniques, and their use may require careful qualification studies.

Variability observed both in preclinical experiments and clinical studies with cell-based products suggest the possibility that heretofore unidentified subpopulations within a heterogeneous product may exert a disproportionate effect on product effectiveness or safety. This uncertainty could confound pivotal trials needed to establish clinical effectiveness. During the presentation, Dr. Moos will explore these questions and discuss possible strategies for addressing them in a practical manner, first to meet regulatory requirements for initiation of human trials, and subsequently for marketing approval.

Dr. Malcolm Moos Jr. is a Medical Officer at FDA/CBER/OCTGT that supports regulatory decisions in the emerging area of cellular therapy. His current research interests are to define how evaluating the status of major cell signaling pathways (BMP, Wnt, etc.) can be used in conjunction with recent developments in systems biology to characterize cell-based products more accurately and to improve product design. His awards include the Harvey W. Wiley Medal, the Center Director’s Targeted Research Award (twice), the Center Director’s Distinguished Service Award, and thirty-one others.

Stem Cell Summit 2013 includes two parallel tracks and this summit provides cutting-edge information on developments in all areas of stem cell research including the biology, medicine, applications, regulations, and commercialization of stem cells.

Track A: Stem Cell Research & Regenerative Medicine:
Joint Session: Funding Opportunities
Joint Session: Regulatory Guidance & Updates
Session: Advances in iPS & ES Cells
Session: Advances in Adult Stem Cells
Session: New Paradigms for Cell Therapy

Track B: Stem Cell Commercialization & Partnering:
Joint Session: Funding Opportunities
Joint Session: Regulatory Guidance & Update
Session: Novel Technologies in Stem Cell Research
Session: Overcoming Challenges in Clinical Development
Session: Commercialization: Bringing Therapeutics to Market
Session: Partnerships & Acquisitions.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Malcolm Moos of FDA/CBER/OCTGT to Present at the Stem Cell Summit 2013 on April 29-30 in Boston

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR
Commodity Chemicals Market Projected to be Resilient by 2020 Says Persistence Market Research
Cell Expansion Market Set to Garner Staggering Revenues by 2025 Reports PMR
Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research
Persistence Market Research Publishes Biopharmaceutical Membrane Filtration Market Forecast Over 2017-2025
Global Tablet Processing & Packaging Equipment Market to Reach USD 5,268.8 Million by 2022

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  MagLar, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)